This map shows the geographic impact of G Pizzorno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Pizzorno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Pizzorno more than expected).
This network shows the impact of papers produced by G Pizzorno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Pizzorno. The network helps show where G Pizzorno may publish in the future.
Co-authorship network of co-authors of G Pizzorno
This figure shows the co-authorship network connecting the top 25 collaborators of G Pizzorno.
A scholar is included among the top collaborators of G Pizzorno based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with G Pizzorno. G Pizzorno is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Burtness, Barbara, et al.. (2001). A phase I study of the antimetabolite (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731) administered as a twice-weekly infusion.. PubMed. 6(5). 309–15.6 indexed citations
3.
Cao, Dandan, Manjunath Nimmakayalu, Fu Wang, et al.. (1999). Genomic structure, chromosomal mapping, and promoter region analysis of murine uridine phosphorylase gene.. PubMed. 59(19). 4997–5001.12 indexed citations
4.
Liu, Menghan, Deliang Cao, Rosalind L. Russell, Robert E. Handschumacher, & G Pizzorno. (1998). Expression, characterization, and detection of human uridine phosphorylase and identification of variant uridine phosphorolytic activity in selected human tumors.. PubMed. 58(23). 5418–24.55 indexed citations
5.
Pizzorno, G, Lorrin Yee, Barbara Burtness, et al.. (1998). Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor.. PubMed. 4(5). 1165–75.35 indexed citations
Pizzorno, G, Barbara A. Moroson, Arlene R. Cashmore, et al.. (1995). Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM.. PubMed. 55(3). 566–73.55 indexed citations
Pizzorno, G, et al.. (1992). Brequinar potentiates 5-fluorouracil antitumor activity in a murine model colon 38 tumor by tissue-specific modulation of uridine nucleotide pools.. PubMed. 52(7). 1660–5.23 indexed citations
15.
Pizzorno, G, Barbara A. Moroson, Arlene R. Cashmore, & G. Peter Beardsley. (1991). (6R)-5,10-Dideaza-5,6,7,8-tetrahydrofolic acid effects on nucleotide metabolism in CCRF-CEM human T-lymphoblast leukemia cells.. PubMed. 51(9). 2291–5.21 indexed citations
Pizzorno, G, Enrico Mini, Marcella Coronnello, et al.. (1988). Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug.. PubMed. 48(8). 2149–55.93 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.